Mason Street Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-185,680
| Closed | -$21.8M | – | 734 |
|
|
2020
Q4 | $21.8M | Sell |
185,680
-3,118
| -2% | -$343K | 0.37% | 45 |
|
|
2020
Q3 | $19.6M | Sell |
188,798
-2,659
| -1% | -$267K | 0.38% | 43 |
|
|
2020
Q2 | $17.6M | Buy |
191,457
+216
| +0.1% | +$20.7K | 0.35% | 49 |
|
|
2020
Q1 | $17.2M | Hold |
191,241
| – | – | 0.4% | 44 |
|
|
2019
Q4 | $21.7M | Buy |
191,241
+97
| +0.1% | +$10.6K | 0.42% | 37 |
|
|
2019
Q3 | $20.8M | Sell |
191,144
-63
| -0% | -$6.57K | 0.43% | 39 |
|
|
2019
Q2 | $18.6M | Sell |
191,207
-126
| -0.1% | -$11.5K | 0.39% | 41 |
|
|
2019
Q1 | $17.4M | Buy |
191,333
+1,983
| +1% | +$177K | 0.35% | 47 |
|
|
2018
Q4 | $17.2M | Sell |
189,350
-503
| -0.3% | -$47K | 0.42% | 42 |
|
|
2018
Q3 | $18.7M | Sell |
189,853
-147
| -0.1% | -$13.6K | 0.39% | 43 |
|
|
2018
Q2 | $16.3M | Buy |
190,000
+1,215
| +0.6% | +$101K | 0.36% | 49 |
|
|
2018
Q1 | $15.1M | Buy |
188,785
+241
| +0.1% | +$19.9K | 0.35% | 48 |
|
|
2017
Q4 | $15.2M | Buy |
188,544
+502
| +0.3% | +$40.2K | 0.34% | 51 |
|
|
2017
Q3 | $14.6M | Sell |
188,042
-1,944
| -1% | -$161K | 0.35% | 52 |
|
|
2017
Q2 | $16.9M | Buy |
189,986
+816
| +0.4% | +$68.8K | 0.42% | 40 |
|
|
2017
Q1 | $15.2M | Buy |
189,170
+1,343
| +0.7% | +$105K | 0.39% | 40 |
|
|
2016
Q4 | $13.4M | Buy |
187,827
+880
| +0.5% | +$69.1K | 0.36% | 44 |
|
|
2016
Q3 | $16.2M | Sell |
186,947
-2,454
| -1% | -$214K | 0.46% | 35 |
|
|
2016
Q2 | $16.4M | Buy |
189,401
+2,099
| +1% | +$170K | 0.48% | 39 |
|
|
2016
Q1 | $14M | Buy |
187,302
+3,603
| +2% | +$271K | 0.43% | 43 |
|
|
2015
Q4 | $14.1M | Buy |
183,699
+723
| +0.4% | +$54.4K | 0.44% | 41 |
|
|
2015
Q3 | $12.2M | Sell |
182,976
-522
| -0.3% | -$38.4K | 0.41% | 45 |
|
|
2015
Q2 | $13.6M | Sell |
183,498
-28
| -0% | -$2.14K | 0.42% | 45 |
|
|
2015
Q1 | $14.3M | Sell |
183,526
-367,041
| -67% | -$27.8M | 0.43% | 42 |
|
|
2014
Q4 | $39.8M | Buy |
550,567
+80,126
| +17% | +$5.57M | 0.28% | 67 |
|
|
2014
Q3 | $29.1M | Buy |
470,441
+125,582
| +36% | +$7.98M | 0.23% | 94 |
|
|
2014
Q2 | $22M | Sell |
344,859
-22,705
| -6% | -$1.38M | 0.17% | 141 |
|
|
2014
Q1 | $22.6M | Sell |
367,564
-22,300
| -6% | -$1.3M | 0.18% | 143 |
|
|
2013
Q4 | $22.4M | Buy |
389,864
+200,652
| +106% | +$11.4M | 0.18% | 132 |
|
|
2013
Q3 | $10.1M | Sell |
189,212
-113,959
| -38% | -$6.13M | 0.11% | 231 |
|
|
2013
Q2 | $15.6M | Buy |
+303,171
| New | +$15M | 0.17% | 160 |
|
Other funds holding MDT
Mason Street Advisors's MDT Position: Q1 2021 in Review
Mason Street Advisors sold out of Medtronic (MDT) in Q1 2021, closing a stake of 185,680 shares — an estimated $21.8M sold.
Mason Street Advisors first reported a position in MDT in Q2 2013 and held it in 31 quarters. The position peaked at $39.8M in Q4 2014. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.
- Mason Street Advisors reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 185,680 Medtronic shares in Q1 2021, an estimated $21.8M.
- Mason Street Advisors first reported a position in Medtronic in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Medtronic position peaked at $39.8M in Q4 2014.
- 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.